Overall, we showed that the SHH pathway is specifically reactivated in human CRCC and that targeting this pathway might be particularly efficient against this disease, not only through inhibition of tumor growth but also by impeding tumor vascularization. The gene discussed is SHH; the disease is chromophobe renal cell carcinoma.